Univariate analyses of the cellular composition of the graft on EFS
| . | Mean ± SD . | Relative risk . | (95% CI) . | P . |
|---|---|---|---|---|
| Total cells (×108/kg) | 2.9 ± 0.73 | .84 | (0.60-1.2) | .29 |
| CFU-GM (×104/kg) | 6.1 ± 5.5 | .99 | (0.94-1.0) | .77 |
| CFU-GEMM (×104/kg) | 1.8 ± 1.6 | .90 | (0.76-1.1) | .27 |
| CFU-TOT (×104/kg) | 70.0 ± 43 | .99 | (0.99-1.0) | .12 |
| CD34+(×106/kg) | 3.1 ± 1.3 | .79 | (0.64-0.97) | .028 |
| CD34+, CD38−(×106/kg) | 0.13 ± 0.1 | .074 | (0.004-1.3) | .077 |
| CD3+(×106/kg) | 25 ± 9.7 | .99 | (0.96-1.0) | .33 |
| CD3+, CD4+, CD8−(×106/kg) | 13 ± 5.4 | .98 | (0.94-1.0) | .26 |
| CD3+, CD4−, CD8+(×106/kg) | 8.8 ± 3.8 | .99 | (0.93-1.1) | .86 |
| CD3+, CD4−, CD8−(×106/kg) | 0.77 ± 0.5 | .92 | (0.56-1.5) | .73 |
| CD3+, CD56+(×106/kg) | 1.7 ± 2.3 | .89 | (0.75-1.0) | .14 |
| CD19+(×106/kg) | 7.8 ± 4.1 | .95 | (0.89-1.0) | .10 |
| CD3−, CD56+(×106/kg) | 2.2 ± 1.3 | .97 | (0.80-1.2) | .77 |
| CD3−, CD4−, CD8lo(×106/kg) | 1.0 ± 0.8 | 1.1 | (0.85-1.5) | .39 |
| CD3−, CD4lo, CD8−(×106/kg) | 12.1 ± 5.5 | .99 | (0.95-1.0) | .65 |
| CD3−, CD4+, CD8−(×106/kg) | 0.80 ± 0.4 | 2.2 | (1.2-3.8) | .0072 |
| . | Mean ± SD . | Relative risk . | (95% CI) . | P . |
|---|---|---|---|---|
| Total cells (×108/kg) | 2.9 ± 0.73 | .84 | (0.60-1.2) | .29 |
| CFU-GM (×104/kg) | 6.1 ± 5.5 | .99 | (0.94-1.0) | .77 |
| CFU-GEMM (×104/kg) | 1.8 ± 1.6 | .90 | (0.76-1.1) | .27 |
| CFU-TOT (×104/kg) | 70.0 ± 43 | .99 | (0.99-1.0) | .12 |
| CD34+(×106/kg) | 3.1 ± 1.3 | .79 | (0.64-0.97) | .028 |
| CD34+, CD38−(×106/kg) | 0.13 ± 0.1 | .074 | (0.004-1.3) | .077 |
| CD3+(×106/kg) | 25 ± 9.7 | .99 | (0.96-1.0) | .33 |
| CD3+, CD4+, CD8−(×106/kg) | 13 ± 5.4 | .98 | (0.94-1.0) | .26 |
| CD3+, CD4−, CD8+(×106/kg) | 8.8 ± 3.8 | .99 | (0.93-1.1) | .86 |
| CD3+, CD4−, CD8−(×106/kg) | 0.77 ± 0.5 | .92 | (0.56-1.5) | .73 |
| CD3+, CD56+(×106/kg) | 1.7 ± 2.3 | .89 | (0.75-1.0) | .14 |
| CD19+(×106/kg) | 7.8 ± 4.1 | .95 | (0.89-1.0) | .10 |
| CD3−, CD56+(×106/kg) | 2.2 ± 1.3 | .97 | (0.80-1.2) | .77 |
| CD3−, CD4−, CD8lo(×106/kg) | 1.0 ± 0.8 | 1.1 | (0.85-1.5) | .39 |
| CD3−, CD4lo, CD8−(×106/kg) | 12.1 ± 5.5 | .99 | (0.95-1.0) | .65 |
| CD3−, CD4+, CD8−(×106/kg) | 0.80 ± 0.4 | 2.2 | (1.2-3.8) | .0072 |
Separate regression analyses were performed for the entire group of patients (n = 113) using each covariate listed. Significant (P < .05) associations of covariates with EFS are in bold.